Vince
Super Moderator
A major preventive effect from resistant starch on a wide range of cancers has been shown in a trial in people with high hereditary risk. Resistant starch can be found in a broad variety of foods such as oats, breakfast cereal, cooked and cooled pasta or rice, peas and beans, and slightly green bananas.
An international trial revealed that a regular dose of resistant starch, also known as fermentable fiber, taken for an average of two years, did not affect cancers in the bowel but did reduce cancers in other parts of the body by more than half. This effect was particularly pronounced for upper gastrointestinal cancers including oesophageal, gastric, biliary tract, pancreatic, and duodenum cancers. The trial – known as CAPP2 – involved almost 1000 patients with Lynch syndrome from around the world.
Moreover, the astonishing effect was seen to last for 10 years after stopping taking the supplement.
The study is a planned double-blind 10-year follow–up, supplemented with comprehensive national cancer registry data for up to 20 years in 369 of the participants. The research was led by experts at the Universities of Newcastle and Leeds and published on July 25, 2022, in Cancer Prevention Research, a journal of the American Association for Cancer Research.
An international trial revealed that a regular dose of resistant starch, also known as fermentable fiber, taken for an average of two years, did not affect cancers in the bowel but did reduce cancers in other parts of the body by more than half. This effect was particularly pronounced for upper gastrointestinal cancers including oesophageal, gastric, biliary tract, pancreatic, and duodenum cancers. The trial – known as CAPP2 – involved almost 1000 patients with Lynch syndrome from around the world.
Moreover, the astonishing effect was seen to last for 10 years after stopping taking the supplement.
The study is a planned double-blind 10-year follow–up, supplemented with comprehensive national cancer registry data for up to 20 years in 369 of the participants. The research was led by experts at the Universities of Newcastle and Leeds and published on July 25, 2022, in Cancer Prevention Research, a journal of the American Association for Cancer Research.
Scientific Trial Proves Diet Supplement Can Prevent Hereditary Cancer
scitechdaily-com.cdn.ampproject.org